Georg Hess
34Patents
7h-index
19Co-inventors
62Inventor score
Filing activity: Jul 6, 2005 → Nov 26, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7655416B2 | Diagnosing risk of cardiovascular complications using natiuretic peptides | Emerging Cross-Sectional Technologies | 8 | Active |
| US7732214B2 | Differentiation of acute and chronic myocardial necrosis in symptomatic patients | Physics | 8 | Active |
| US10234462B2 | Use of mimecan in the assessment of heart failure | Physics | 7 | Active |
| US7608418B2 | NT-proANP and NT-proBNP for diagnosing cardiac diseases | Physics | 7 | Active |
| US7960123B2 | Multimarker panel based on PIGF for diabetes types 1 and 2 | Emerging Cross-Sectional Technologies | 7 | Active |
| US10488422B2 | Use of IGFBP-7 in the assessment of heart failure | Physics | 7 | Active |
| US8361800B2 | Diagnostic means and methods using troponin T and NT-proBNP | Physics | 7 | Active |
| US8003396B2 | NT-proBNP/troponin ratio for assessing myocardial dysfunction | Physics | 7 | Active |
| US7892844B2 | Differentiation of cardiac and pulmonary causes of acute shortness of breath | Physics | 7 | Active |
| US7651679B2 | Biochemical markers for acute pulmonary embolism | Physics | 6 | Active |
| US8691587B2 | Use of SFRP-3 in the assessment of heart failure | Physics | 6 | Active |
| US8486706B2 | L-FABP, natriuretic peptides, and cardiac troponins in subjects in need of cardiac therapy | Emerging Cross-Sectional Technologies | 6 | Active |
| US7820373B2 | Natriuretic peptides and placenta growth factor levels for risk stratification | Physics | 2 | Active |
| US8501155B2 | Biochemical markers for acute pulmonary embolism | Physics | 2 | Active |
| US10996229B2 | Use of IGFBP-7 in the assessment of heart failure | Physics | 1 | Active |
| US9267954B2 | Use of SLIM-1 in the assessment of heart failure | Physics | 1 | Active |
| US7927812B2 | Cardiac troponin as an indicator of coronary artery disease | Physics | 1 | Active |
| US9983213B2 | Identification of subjects being susceptible to anti-angiogenesis therapy | Physics | 0 | Active |
| US8771961B2 | Monitoring myocardial infarction and its treatment | Physics | 0 | Active |
| US7955854B2 | Assessing heart failure in patients with atrial fibrillation using GDF-15 and natriuretic peptides | Physics | 0 | Active |
| US8663941B2 | Method for diagnosing and monitoring cardiac ischemia in patients with acute chest pain and without myocardial infarction | Physics | 0 | Active |
| US10732188B2 | NT-proANP and NT-proBNP for the diagnosis of stroke | Physics | 0 | Active |
| US8497095B2 | Biochemical markers for acute pulmonary embolism | Physics | 0 | Active |
| US7977105B2 | Myoglobin as early predictor of myocardial infarction | Physics | 0 | Active |
| US8062857B1 | H-FABP as early predictor of myocardial infarction | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.